A complete response to brentuximab vedotin, a monoclonal antibody to CD30 linked to the cytotoxic compound monomethyl auristatin E, has also shown efficacy in PC-ALCL. The gene discussed is TNFRSF8; the disease is anaplastic large cell lymphoma.